Editorial
doi: 10.1016/s8756-3282(00)00399-9.
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
- PMID: 11113386
- DOI: 10.1016/s8756-3282(00)00399-9
Item in Clipboard
Editorial
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Bone.
2000 Dec.
No abstract available
Similar articles
-
Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.CMAJ. 2002 May 28;166(11):1426-30. CMAJ. 2002. PMID: 12054412 Free PMC article. No abstract available.
-
Risedronate prevents hip fractures, but who should get therapy?Cleve Clin J Med. 2002 Dec;69(12):964, 968-70, 973-6. doi: 10.3949/ccjm.69.12.964. Cleve Clin J Med. 2002. PMID: 12546269 Review.
-
Risedronate treatment and extended fracture protection in postmenopausal women.Clin Exp Rheumatol. 2001 Nov-Dec;19(6):625-6. Clin Exp Rheumatol. 2001. PMID: 11791630 No abstract available.
-
Aging bone and osteoporosis: strategies for preventing fractures in the elderly.Arch Intern Med. 2003 Oct 13;163(18):2237-46. doi: 10.1001/archinte.163.18.2237. Arch Intern Med. 2003. PMID: 14557222 Review.
-
[Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].Ned Tijdschr Geneeskd. 2001 Jul 14;145(28):1336-8. Ned Tijdschr Geneeskd. 2001. PMID: 11484428 Review. Dutch.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
